HHS Seeks More Authority for 340B Pricing Data Collection and Oversight

Drug Industry Daily
HHS needs more authority to audit entities such as hospitals and clinics under the 340B drug pricing program to determine how much they save and what they spend their savings on, an agency official told the Senate HELP committee Tuesday.

To View This Article:


Subscribe To Drug Industry Daily